Trial
NCT02130817
Belatacept in Kidney Transplantation of Moderately Sensitized Patients
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
Bristol-Myers Squibb
Condition
End Stage Renal Disease
Intervention
Belatacept
Why stopped
Organ transplant criteria made recruitment difficult. Closed with IRB 10/09/2015.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-17